ATOMY MINERAL COMPACT NO.25
- Manufacturer
- ATOMY CO., LTD. | Kolmar Korea Co.,Ltd. Bucheon Factory
- Effective date
- 2020-11-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:06:52
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENTS
TITANIUM DIOXIDE 18.31%, ZINC OXIDE 1.92%
INACTIVE INGREDIENTS
MICA,TALC,SILICA,DIMETHICONE,BORON NITRIDE,IRON OXIDES(CI 77492),DIISOSTEARYL MALATE, TRIFLUOROMETHYL C1-4 ALKYL DIMETHICONE,TRIETHOXYCAPRYLYLSILANE,DIPHENYLSILOXY PHENYL TRIMETHICONE,NYLON-12,POLYMETHYL METHACRYLATE,TRIETHYLHEXANOIN, DIPENTAERYTHRITYL HEXAHYDROXYSTEARATE/HEXASTEARATE/HEXAROSINATE,
IRON OXIDES(CI 77491),METHICONE,DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, GLYCERYL CAPRYLATE,POLYGLYCERYL-2 TETRAISOSTEARATE,SILICA DIMETHYL SILYLATE,IRON OXIDES(CI 77499),CAPRYLYL GLYCOL,ALUMINUM MYRISTATE,ALUMINUM HYDROXIDE,DISODIUM STEAROYL GLUTAMATE,TRIMETHYLSILOXYSILICATE,FRAGRANCE(PARFUM),MYRISTIC ACID,
PHYTOSTERYL/OCTYLDODECYL LAUROYL GLUTAMATE,TOCOPHERYL ACETATE,ALUMINUM DIMYRISTATE,ALUMINA,AQUA/WATER/EAU,CALCIUM CARBONATE,HYDROXYAPATITE,ZEA MAYS (CORN) STARCH,PISTACIA LENTISCUS (MASTIC) GUM,PROPOLIS WAX,ROYAL JELLY EXTRACT,
ACETYL HEXAPEPTIDE-8
PURPOSE
Sunscreen agent
WARNINGS
For extral use only
UV exposure from the sun increases the risk of skin cancer, premature skin aging and other skin damage.
It is important to decrease UV exporsure by limiting time in the sun, wearing protective clothing, and using a sunscreen.
When using this product, keep out of eyes. Rinse water to remove.
Stop use and ask a doctor, if rash or irritation develops and lasts.
Do not use
• Areas of eczema, skin inflammation, or after injury
When using this produt
• Discontinue use if irritation or rash appear.
• Keep out of eyes
• Rinse with water to remove
Ask a doctor before use if you have
• Poor blood circulation
• Irritated skin
• Any area that is infected or reddened
• Diabetes
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center right away
DESCRIPTION
Uses
• Provides moderate protection against adverse effects of the sun.
• Higher SPF gives more sunburn protection.
• Helps prevent sunburn.
• Effective for the skin highly sensitive to sunburn.
Directions
• Apply liberally before sun exporsure.
• Children under 6 months of age: ask a doctor.
• Reapply as needed or after towel drying, swimming or perspiring.
• Not intended for protection while sunbathing.
Other information
• Store at 20-25 degrees C (68-77 degrees F)
Questions or comments?
1-253-946-2344
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| MICA | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Products#
Every source-derived product name is available through these pages.
- ATOMY MINERAL COMPACT NO.25
- TITANIUM DIOXIDE, ZINC OXIDE
- TITANIUM DIOXIDE
- ZINC OXIDE
- ZINC CATION
- MICA
- TALC
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 52257-1300 | 52257-1300-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| ZINC OXIDE | SOI2LOH54Z | ACTIM |
| MICA | V8A1AW0880 | IACT |
| TALC | 7SEV7J4R1U | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TALC | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| TALC | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| TALC | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| TALC | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| TALC | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg | ||
| TALC | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| TALC | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| TALC | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 35175889-bff2-452f-a7c9-88ec78ed7e08 | 55fb0a65-6d04-49b5-a47d-ebdaa97e9e88 | 2021-10-29 | Warnings | 55fb0a65-6d04-49b5-a47d-ebdaa97e9e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
